Key result
ADPriboDB 2.0 updates its repository to catalog ~48,000 entries of ADP-ribosylated proteins with interactive tools.
Why the study?
To facilitate studies uncovering insights into the mechanisms and biological significance of ADP-ribosylation, an updated repository was developed.
The updated ADPriboDB 2.0 database provides a comprehensive resource for exploring the biology of ADP-ribosylation, including its structural and functional features and associations with viral infections like SARS-CoV-2.
ADPriboDB 2.0 offers a centralized ADP-ribosylation repository; leaves open its utility for cardiovascular research applications.
ADP-ribosylation is a protein modification responsible for biological processes such as DNA repair, RNA regulation, cell cycle and biomolecular condensate formation. Dysregulation of ADP-ribosylation is implicated in cancer, neurodegeneration and viral infection. We developed ADPriboDB (adpribodb.leunglab.org) to facilitate studies in uncovering insights into the mechanisms and biological significance of ADP-ribosylation. ADPriboDB 2.0 serves as a one-stop repository comprising 48 346 entries and 9097 ADP-ribosylated proteins, of which 6708 were newly identified since the original database release. In this updated version, we provide information regarding the sites of ADP-ribosylation in 32 946 entries. The wealth of information allows us to interrogate existing databases or newly available data. For example, we found that ADP-ribosylated substrates are significantly associated with the recently identified human protein interaction networks associated with SARS-CoV-2, which encodes a conserved protein domain called macrodomain that binds and removes ADP-ribosylation. In addition, we create a new interactive tool to visualize the local context of ADP-ribosylation, such as structural and functional features as well as other post-translational modifications (e.g. phosphorylation, methylation and ubiquitination). This information provides opportunities to explore the biology of ADP-ribosylation and generate new hypotheses for experimental testing.
No takes yet. Share an insight, caveat, or question.
Ayyappan et al. (2020) studied this question. ADPriboDB 2.0 was evaluated. ADPriboDB 2.0 is an updated repository comprising 48,346 entries and 9,097 ADP-ribosylated proteins, providing information on ADP-ribosylation sites and interactive visualization tools.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: